CORDIS · 953169 · H2020
InterLynk Human Platelet Lysates-based Scaffolds for Interfacial Multi-tissue Repair
Coordinator: UNIVERSIDADE DE AVEIRO (PT)
InterLynk aims to develop multi-tissue 3D patient-specific scaffolds by providing a portfolio of highly compatible and biofunctional composite inks and biomaterials, and streamlining their co-processing using an upgraded AM equipment. Unprecedented biofunctionality in the synthetic reconstruction of complex interfacial tissues is expected to be obtained. A double network photocrosslinkable biomaterial system based on human plasma-derived Platelet Lysates (PL) will be used as base matrix. The PL-based hydrogels will be further combined with mechanically reinforcing biomaterials, namely CaP-bas…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €6.0M awarded to the consortium. The project runs over approximately 4.6 years from 2021-01-01 to 2025-07-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from PT
see all →- Smart4Health — Citizen-centred EU-EHR exchange for personalised health826117 · H2020 · €21.8M
- GIMM-CARE — GIMM-CARE: BOOSTING CLINICAL RESEARCH FOR THE BENEFIT OF SOCIETY101060102 · HORIZON · €15.0M
- MIA-Portugal — Multidisciplinary Institute of Ageing - Portugal857524 · H2020 · €15.0M
- INESCTEC.OCEAN — Centre of Excellence in Ocean Research and Engineering101136903 · HORIZON · €15.0M
- NIMSB — NOVA Institute for Medical Systems Biology101060346 · HORIZON · €15.0M
- BIOPOLIS — Teaming to Upgrade to Excellence in Environmental Biology, Ecosystem Research and AgroBiodiversity857251 · H2020 · €15.0M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the RIA funding scheme.
- What is the EU contribution?
- The European Commission contributes €6.0M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call H2020-NMBP-TR-IND-2018-2020.
- Who coordinates the project?
- The project is coordinated by UNIVERSIDADE DE AVEIRO (PT).
- What is the project timeline?
- The project runs from 2021-01-01 to 2025-07-31 — approximately 4.6 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 953169.